相关期刊:《Signal Transduction and Targeted Therapy》《Chemical Research in Chinese Universities》《Science China Materials》《Journal of Materials Science & Technology》更多>>
supported by the National Natural Science Foundation of China(Nos.82202274,82072032,22161016,32025021,12374390,52002380 and 31971292),the National Science and Technology Major Project(No.2023ZD0500902);the Fellowship of China Postdoctoral Science Foundation(No.2023M743559);the Member of Youth Innovation Promotion Association Foundation of CAS,China(No.2023310);the Key Scientific and Technological Special Project of Ningbo City(No.2023Z209);the Natural Science Foundation of Zhejiang Province(No.LQ23H180003)。
Recently,stimuli-responsive nanocarriers capable of precision drug release have garnered significant attention in the field of drug delivery.Here,an in-situ dynamic covalent self-assembled(DCS)strategy was utilized to...
supported by the National Key Research and Development Program of China(No.2022YFE0107800);National Natural Science Foundation of China(Nos.82373206,and 82073332);Zhejiang Provincial Natural Science Foundation of China(No.LHDMZ24H300002)。
Traditionally,hyaluronic acid has been widely used for drug delivery,but the current application bottleneck is that hyaluronic acid is hydrophilic and electronegative,which makes it difficult to carry hydrophobic drug...
supported by the grants from the National Natural Science Foundation of China(Nos.81973251 and 81302725);Hebei Province Funding Project for Introduced Overseas Personnel(Nos.C20230351 and C20220345);Key Research and Development Program of Hebei Province(No.22372701D);Hebei Province Natural Science Fund(No.H2020206610);Hebei Provincial Health Commission Government-Funded Clinical Medicine Talent Program(No.ZF2024048);Hebei Medical University Undergraduate Innovative Experiment Program(No.USIP2023008)。
The combination of nucleic acid and small-molecule drugs in tumor treatment holds significant promise;however,the precise delivery and controlled release of drugs within the cytoplasm encounter substantial obstacles,i...
approved by the Institutional Animal Care and Use Committee(IACUC)of the First Affiliated Hospital of Fujian Medical University(No.2023048).
Background:Despite significant advancements in the development of anticancer therapies over the past few decades,the clinical management of colorectal cancer remains a challenging task.This study aims to investigate t...
supported by the National Natural Science Foundation of China(Nos.82073782 and 82241002,China);the Shanghai Science and Technology Committee(No.19430741500,China);National Key Research and Development Program of China(2018YFA0902000,China);the Key Laboratory of Modern Chinese Medicine Preparation of Ministry of Education of Jiangxi University of Traditional Chinese Medicine(zdsys-202103,China).
Multidrug resistance(MDR),the major mechanism by which various cancers develop specific resistance to therapeutic agents,has set up enormous obstacles to many forms of tumor chemotherapy.Traditional cocktail therapy a...
supported by the Natural Science Foundation of Beijing Municipality(L234024)。
Articular cartilage injury(ACI)remains one of the key challenges in regenerative medicine,as current treatment strategies do not result in ideal regeneration of hyaline-like cartilage.Enhancing endogenous repair via m...
supported by National Natural Science Foundation of China(No.82070932);the Zhejiang Provincial Natural Science Foundation of China(No.LY19H120002);the internal funding of Wenzhou Medical University(No.KYYW202020,China);The Project of Wenzhou Medical University Affiliated Eye Hospital(No.YNZD2201901,China);the integration project of State Key Laboratory of Ophthalmology,Optometry and Vision Science(No.J02-20190202,China).
Dexamethasone(DEX)is used to treat ocular surface diseases.However,regulating DEX duration in tears while preventing its absorption into the anterior chamber is critical for balancing its therapy effects and the side ...
supported by the National Natural Science Foundation of China(Grant No.32171367);Natural Science Foundation of Jiangsu Province(Grant No.BK20230236);Science and Technology Project of Suzhou(Grant No.SS202135);CAS-VPST Silk Road Science Fund 2021(Grant No.121E32KYSB20200021).
Mesenchymal stem cells(MSCs)have emerged as promising candidates for idiopathic pulmonary fibrosis(IPF)therapy.Increasing the MSC survival rate and deepening the understanding of the behavior of transplanted MSCs are ...
L.L.thanks the Olav Thon Foundation(Grant Number:21-90)for financial support;D.B.R.thanks Maggie-Stephens Foundation(Grant Number:20202004);Sten K Johnson Foundation(Grant Number:2021-0592);The Crafoord Foundation(2021-0550)for research grants.
Recombinant human bone morphogenetic protein-2(rhBMP-2)has been FDA-approved for lumbar fusion,but supraphysiologic initial burst release due to suboptimal carrier and late excess bone resorption caused by osteoclast ...
supported by the National Natural Science Foundation of China[grant numbers 21873057,22373059];the Natural Science Foundation of Shandong Province[grant numbers ZR2023MB082]。
Despite standard treatment for non-small cell lung cancer(NSCLC)being surgical resection,cancer recurrence and complications,such as induction of malignant pleural effusion(MPE)and significant postoperative pain,usual...